Correlation Between NLS Pharmaceutics and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on NLS Pharmaceutics and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Dermata Therapeutics.
Diversification Opportunities for NLS Pharmaceutics and Dermata Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between NLS and Dermata is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Dermata Therapeutics
Assuming the 90 days horizon NLS Pharmaceutics is expected to generate 29.97 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, NLS Pharmaceutics AG is 9.98 times less risky than Dermata Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.81 in Dermata Therapeutics Warrant on September 1, 2024 and sell it today you would earn a total of 0.07 from holding Dermata Therapeutics Warrant or generate 8.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 42.06% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
| NLS Pharmaceutics |
| Dermata Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
NLS Pharmaceutics and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Dermata Therapeutics
The main advantage of trading using opposite NLS Pharmaceutics and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Dermata Therapeutics vs. Tff Pharmaceuticals | Dermata Therapeutics vs. Eliem Therapeutics | Dermata Therapeutics vs. Inhibrx | Dermata Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |